Traders sold shares of Elanco Animal Health (NASDAQ:ELAN) on strength during trading on Tuesday. $70.34 million flowed into the stock on the tick-up and $147.30 million flowed out of the stock on the tick-down, for a money net flow of $76.96 million out of the stock. Of all equities tracked, Elanco Animal Health had the 32nd highest net out-flow for the day. Elanco Animal Health traded up $1.19 for the day and closed at $32.83

ELAN has been the subject of several research analyst reports. Zacks Investment Research downgraded Elanco Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 5th. Credit Suisse Group reissued a “hold” rating and issued a $36.00 price objective on shares of Elanco Animal Health in a research note on Monday, December 17th. BMO Capital Markets reduced their price objective on Elanco Animal Health from $37.00 to $32.00 and set a “market perform” rating for the company in a research note on Wednesday, December 19th. They noted that the move was a valuation call. Bank of America raised Elanco Animal Health from a “neutral” rating to a “buy” rating and set a $30.95 price objective for the company in a research note on Monday. Finally, Morgan Stanley initiated coverage on Elanco Animal Health in a research note on Wednesday, March 13th. They issued an “equal weight” rating and a $34.00 price objective for the company. One analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the company’s stock. Elanco Animal Health has an average rating of “Hold” and an average target price of $33.22.

Elanco Animal Health (NASDAQ:ELAN) last posted its quarterly earnings results on Wednesday, February 6th. The company reported $0.29 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.26 by $0.03. The firm had revenue of $799.30 million for the quarter, compared to analysts’ expectations of $804.07 million. During the same period last year, the business earned $0.12 earnings per share. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis.

In other news, Director R David Hoover purchased 20,000 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was bought at an average cost of $31.43 per share, with a total value of $628,600.00. The acquisition was disclosed in a document filed with the SEC, which is available through this link.

Institutional investors and hedge funds have recently bought and sold shares of the company. Macquarie Group Ltd. purchased a new stake in shares of Elanco Animal Health during the 3rd quarter worth about $3,489,000. Chartwell Investment Partners LLC purchased a new stake in shares of Elanco Animal Health during the 4th quarter worth about $251,000. Franklin Resources Inc. purchased a new stake in shares of Elanco Animal Health during the 3rd quarter worth about $60,016,000. Janus Henderson Group PLC purchased a new stake in shares of Elanco Animal Health during the 3rd quarter worth about $68,975,000. Finally, LPL Financial LLC purchased a new stake in shares of Elanco Animal Health during the 3rd quarter worth about $313,000.

WARNING: “Traders Sell Shares of Elanco Animal Health (ELAN) on Strength (ELAN)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/traders-sell-shares-of-elanco-animal-health-elan-on-strength-elan/2902675.html.

Elanco Animal Health Company Profile (NASDAQ:ELAN)

There is no company description available for Elanco Animal Health Inc

Featured Story: Capital Gains

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.